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Synthesis of VLCFAs (very long chain fatty acids) and biosyn-
thesis of DHS (dihydrosphingosine) both are of vital importance
for Saccharomyces cerevisiae. The bulk of VLCFAs and DHS
are used for ceramide synthesis by the Lag1p (longevity-
assurance gene 1)/Lac1p (longevity-assurance gene cognate
1)/Lip1p (Lag1p/Lac1p interacting protein) ceramide synthase.
LAG1 and LAC1 are redundant but LIP1 is essential. Here we show
that 4 (lag1lac1ypc1ydc1) cells devoid of all known
endogenous ceramide synthesis pathways are unviable but can be
rescued by the expression of Lass5, a mouse LAG1 homologue.
Ceramide synthase activity of 4.Lass5 cells only utilizes C16 and
C18 fatty acids and does not require the help of Lip1p, an essential
cofactor of Lag1p/Lac1p. HPLC-electrospray ionization-MS/MS
analysis demonstrated that in IPCs (inositolphosphorylceramides)
of 4.Lass5, the very long chain fatty acids (C26 and C24)
account for <1% instead of the normal >97%. Notwithstanding,
IPCs incorporated into glycosylphosphatidylinositol anchors of
4.Lass5 show normal mobility on TLC and the ceramide-
and raft-dependent traffic of Gas1p (glycophospholipid-anchored
surface protein) from endoplasmic reticulum to Golgi remains
almost normal. Moreover, the biosynthesis of C24:0 fatty acids
remains essential. Thus, C24:0 and dihydrosphingosine are both
necessary for survival of yeast cells even if they utilize C16 and
C18 fatty acids for sphingolipid biosynthesis.
Key words: ceramide, ceramide synthase, fatty acid elongation,
longevity-assurance gene 1 (LAG1), Lass5, sphingolipid.
INTRODUCTION
Sphingolipids of the yeast Saccharomyces cerevisiae, the IPCs
(inositolphosphorylceramides), MIPCs (mannosyl-IPCs) and
M(IP)2Cs (inositolphosphoryl-MIPCs) (Figure 1) are major
components of the plasma membrane and the biosynthesis of IPCs
is vital [1]. Contrary to humans, yeast only makes sphingolipids
containing VLCFAs (very long chain fatty acids), namely C26:0
and minor amounts of C24:0, C22:0, C22:1, C20:0, C20:1, but no LCFAs
(long chain fatty acids) such as C18 and C16 [2,3]. Yeast
sphingolipids contain PHS (phytosphingosine) and small amounts
of DHS (dihydrosphingosine), but no sphingosine, the desaturated
LCB (long chain base) typically present in mammals. Yeast
sphingolipids act not only as structural components of membranes
and rafts but DHS and PHS as well as their 1-phosphorylated deri-
vatives are also proposed to act as signal transduction molecules
governing heat stress responses, endocytosis, ubiquitin-dependent
degradation of membrane channels and progression through G1-
phase [1,4]. While signal pathways controlled by PHS are quite
well understood, much less is known about signalling functions of
ceramide. On the other hand, the ER (endoplasmic reticulum) to
Golgi transport of GPI (glycosylphosphatidylinositol) proteins
has been shown to be dependent on ongoing sphingolipid
synthesis, and the critical role is played by ceramides and/or
inositolphospholipids [5–7]. Gas1p (glycophospholipid-anchored
surface protein) has been shown to associate with lipid rafts in the
ER and the formation of these rafts is dependent on sphingolipid
biosynthesis [8]. Thus, the role of sphingolipids in GPI protein
transport may be related to raft formation [7,8]. In further support
of this, the transport of Gas1p to the Golgi is specifically and
severely retarded if the elongation of C24 to C26 fatty acids by Elo3p
is abolished [9], and it is also slowed when ceramide synthesis is
blocked in lag1 (longevity-assurance gene 1)∆ lac1 (longevity-
assurance gene cognate 1)  cells [10].
The biosynthesis of ceramide in yeast is dependent on LAG1
(Figure 1), which is a member of a large eukaryotic gene family
[11–14]. The simultaneous deletion or depletion of LAG1 and
its close homologue LAC1 in yeast eliminates all detectable
acyl-CoA-dependent ceramide biosynthesis in microsomes. The
lag1∆ lac1∆ cells show a dramatic reduction of IPCs and a
marked accumulation of free DHS and PHS [11]. The concomitant
deletion of LAG1 and LAC1 causes a significant growth defect
in the genetic background of W303 cells and the same double
deletion does not yield viable cells in the YPK9 background,
which was used for the present study [10–12]. Lag1p and Lac1p
interact with each other and with Lip1p (Lag1p/Lac1p interacting
protein 1), a single span membrane protein that is equally
required for acyl-CoA-dependent ceramide biosynthesis [15].
Lip1p is essential for S. cerevisiae but no mammalian homologue
of LIP1 has been identified (Figure 1). In the absence of the
acyl-CoA-dependent ceramide synthase, two highly homologous
ceramidases, Ypc1p (yeast phytoceramidase) and Ydc1p (yeast
dihydroceramidase), can synthesize ceramides from free fatty
acids and LCBs by a reverse ceramidase reaction (Figure 1)
[13,16,17].
In certain conditions, yeast cells can survive without sphin-
golipids. Indeed, deletion of LCB1 (Figure 1A) can be sup-
pressed by a gain of function mutation in SLC1 (sphingolipid
Abbreviations used: 4, lag1lac1ypc1ydc1; DHS, dihydrosphingosine; ER, endoplasmic reticulum; ESI, electrospray ionization; Gas1p,
glycophospholipid-anchored surface protein; GPI, glycosylphosphatidylinositol; IPC, inositolphosphorylceramide; LAC1, longevity-assurance gene
cognate 1; LAG1, longevity-assurance gene 1; LCB, long chain base; LCFA, long chain fatty acid; LM, Lester medium; Lip1p, Lag1p/Lac1p interacting
protein 1; MIPC, mannosylated IPC; M(IP)2C, inositolphosphoryl-MIPC; PE, phosphatidylethanolamine; PHS, phytosphingosine; PI, phosphatidylinositol;
SLC1, sphingolipid compensation 1; ts, temperature sensitive; TSC13, temperature-sensitive Csg2 suppressor; URA3, URAcil requiring; VLCFA, very long
chain fatty acid; WT, wild-type; Ydc1p, yeast dihydroceramidase; Ypc1p, yeast phytoceramidase.
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Figure 1 Sphingolipid biosynthesis in Saccharomyces cerevisiae
(A) Biosynthesis of ceramides (underlined). (B) Generation of mature sphingolipids from
ceramide. Gene names and inhibitors are in italics.
compensation 1) allowing for the incorporation of C26:0 into the
sn-2 position of PI (phosphatidylinositol) [18]. The resulting
VLCFA–PI is mannosylated, indicating that later acting enzymes
of the sphingolipid biosynthetic pathway mistake VLCFA–PI for
IPC [19]. These sphingolipid-like, PI-based phosphoinositides are
believed to rescue lcb1 cells by restoring essential properties to
membranes.
The elaboration of C26- and C24-CoA depends on ELO3 and
ELO2 respectively, as well as TSC13 (temperature-sensitive Csg2
suppressor), which encodes an enoyl reductase acting in each
cycle of fatty acid elongation (Figure 1A) [3,20]. Simultaneous
deletion of ELO2 and ELO3 is lethal, deletion of ELO2 strongly
diminishes the amounts of VLCFAs made, while deletion of ELO3
abolishes the synthesis of C26-CoA, but this is compensated by an
increase of C24- and C22-CoA. Deletion of TSC13 is also lethal.
ELO3 mutants have decreased amounts of complex sphingolipids,
and exhibit a large panel of abnormal phenotypes and genetic
interactions [3,9,20–24].
Lac1p and Lag1p dependent ceramide synthesis strongly pre-
fers C26- and C24-CoA over shorter fatty acid CoA derivatives
[25]. Human LAG1 homologues LASS1, LASS2 and LASS4 can
rescue lag1 lac1 and have, when expressed in yeast, a pre-
ference for C26:0- or C24:0-CoA (Table 1). Overexpression of the
murine Lass5 in human cells, however, showed a clear preference
of this homologue for C16 and C18 fatty acids [26,27]. Here we
show that the same is true, when Lass5 is expressed in budding
yeast and that yeast cells survive without the normal set of
VLCFA-containing sphingolipids.
MATERIALS AND METHODS
Strains, growth conditions and materials
S. cerevisiae strains used are listed in Table 2. Mutants bearing
single deletions of non-essential genes were obtained from
EUROSCARF (EUROpean S. Cerevisiae ARchive for Functional
analysis, Frankfurt, Germany). Cells were grown at 30 ◦C on rich
medium {YPD [1% (w/v) yeast extract/2% (w/v) peptone/2%
(w/v) glucose] or YPG [1% (w/v) yeast extract/2% (w/v)
peptone/2% (w/v) galactose]} or minimal media (SD or SG) [28]
containing 2% (w/v) glucose or galactose as a carbon source and
uracil, adenine and amino acids as required. Alternatively, LM
(Lester medium), a medium specially designed for growing cells
unable to make sphingolipids, was used [29]. Methionine was
added at 20 mg/l, which allowed the reduction of transcription
from the MET17 promoter by 40% [30]. Plates containing
haloperidol (H1512; Sigma) were supplemented with 0.1%
Tween 20 and 0.9% ethanol to facilitate drug solubilization.
Haloperidol was prepared as a 50 mM stock solution in ethanol.
To assess chitin production, cells were streaked on YPD plates
containing 0, 25 or 50 µg/ml of Calcofluor White (Fluorescent
Brightener 28, F-3543; Sigma). To stain cells with Calcofluor
White, cells were kept in continuous exponential growth for
>6 generations, 1 A600 unit of cells was washed with water, stained
in Calcofluor White (1 mg/ml) and observed under an Axioplan
2 (Zeiss) microscope.
Construction of strains and plasmids
The Lass5 (product IRAVp968F0719D) cloned into the pCMV-
SPORT6 plasmid was from the RZPD (German Resource Center
for Genome Research; http://www.rzpd.de) and linearized with
ScaI. The Lass5 open reading frame of IRAVp968F0719D was
Table 1 Reported fatty acyl-CoA preferences of mammalian LASS family members
LASS genes having the same number are very closely related. Shown are human and mouse homologues, the human ones in capitals.
Current name Old name Accession number Mammalian cells in vivo Mammalion cells in vitro Yeast in vitro
LASS1 UOG1 NM 021267 – – C26:0 [25]
Lass1 uog1 NM 138647 C18:0 [55] C18:0 [27,55] –
LASS2 clone 1 BC010032 – – C24:0 [25]
Lass2 trh3 BC006847 VLCFA> C22:0> C24:0 > C26:0 ≈ –
LCFA [27] C18:0 [27]
Lass3 XM 907730 C24>C22:0≈C18:0 C18:0≈C22:0≈C24> –
C26:0 ≈ C16:0 > C20:0 [54]
LASS4 clone 4 AK022151 – – C24:0> C20:0 > C18:0 [25]
Lass4 trh1 BC003946 C18:0> C22:0> C24:0 ≈ C18:0> –
C20:0> C26:0 > C16:0 > C14:0 [27]
C22:0 [26] and C18:0 > C20:0 > C22:0 [26]
Lass5 trh4 BC046797 C16:0 only [26] C14:0≈C16:0 C18:0≈ C12:0 ≈ 14:0≈
C18:1 > C12:0 [27] C16:0 ≈ C18:0 ≈ C18:1 this study
Lass6 trh1 like BC057629 LCFA>VLCFA [27] C14:0≈C16:0C18:0 ≈ C12:0 [27] –
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Table 2 Yeast saccharomyces cerevisiae strains
Strains Genotype Reference
W303-1A MATa can1-100 ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 [11]
YPK9 MATa ade2-101ochre his3-∆200 leu2-∆1 lys2-801amber trp1-∆63 ura3-52 [11]
YPK11 MATα ade2-101ochre his3-∆200 leu2-∆1 lys2-801amber trp1-∆63 ura3-52 Michal Jazwinski
2.LAG1 Same as YPK9 but lag1::TRP1 lac1::LEU2 containing pBM150:LAG1* [11]
4.LAG1 Same as YPK9 but lag1::TRP1 lac1::LEU2 This study
ydc1::natMX ypc1::kanMX4 containing pBM150:LAG1*
4.Lass5 Same as 4.LAG1 but containing p413MET:Lass5 instead of pBM150:LAG1* This study
4.Lass5-ADE2 Same as YPK9 but lag1::TRP1 lac1::LEU2 This study
ydc1::natMX ypc1::kanMX4::ADE2 containing p413MET:Lass5
4.Lass5 elo3 Same as 4.Lass5-ADE2 containing elo3::kanMX This study
2.Lass5 Same as YPK9, but MATα lac1∆::LEU2 This study
lag1::TRP1 and containing p413MET:Lass5
4.Lass5-URA3 Same as YPK9 but lag1::TRP1 lac1::LEU2 This study
ydc1::natMX ypc1::kanMX4::URA3 containing p413MET:Lass5
4.Lass5 lip1 Same as 4.Lass5-URA3 but lip1::kanMX4 This study
lcb1-100 MATa end8-1 leu2 ura3 his4 bar1 R. Schneiter
4R3 lcb1::URA3 SLC1-1 ura3-52 leu2-3,112 ade1 MEL1 R. Dickson
SJ21R ura3-52 leu2-3,112 ade1 K. Athenstaedt
BY4742 MATα his31 leu20 lys20 ura30 EUROSCARF
vma4 YOR332w::kanMX4 in BY4742 EUROSCARF
elo3-1 YLR372w::kanMX4 in BY4742 EUROSCARF
elo3-2 YLR372w::his5+ in YPK11 This study
ypc1 ydc1 Same as YPK9 but ypc1::kanMX4 ydc1::kanMX4::natMX This study
sec18 MATα sec18ts Howard Riezman
* pBM150 is a CEN-ARS, URA3 vector possessing the yeast GAL1,10 promoter.
amplified by PCR using primers Lass5 BamHI.F1 (5′-CACGG-
ATCCTATATAATGGCGACTGCAGCAGCG-3′) and Lass5
EcoRI.R3 (5′-GTTCGTAATAGAATTCGCTAGTCACAGGAG-
TGTAGAT-3′). The PCR product and the p413MET25 plasmid
[30] were digested with EcoRI and BamHI, and ligated to generate
p413MET-Lass5. This plasmid was transfected into Escherichia
coli HB101 cells. The inserted Lass5 sequence was verified by
sequencing and exactly matched the 414 amino acid protein se-
quence predicted by the NCBI entry number AY029533. To ob-
tain the 4.Lass5 strain we used 2.LAG1 [11], a lac1 lag1
strain viable on galactose because it contains pBM150-LAG1,
a CEN-ARS-URA3 (URAcil requiring) vector possessing LAG1
behind the yeast GAL1,10 promoter. YDC1 was deleted in
2.LAG1 using a ydc1::KanMX4 deletion cassette, KanMX4
was then replaced by NatMX4 from pAG25 [31], and finally,
YPC1 was deleted using a ypc1::KanMX4 cassette to generate
4.LAG1. The 2.LAG1 and 4.LAG1 strains were transfected
with p413MET-Lass5 and growing His+ clones were streaked out
on 5-fluoro-orotic acid to shuffle out pBM150-LAG1. Whereas,
non-transfected 2.LAG1 and 4.LAG1 were unable to grow on
5-fluoro-orotic acid, 12 out of 12 His+ clones immediately grew
in the presence of the drug (results not shown). Replacement
of ELO3, TSC13, and LIP1 open reading frames by KanMX4
respectively, were done using standard procedures in 4.Lass5
derivatives, in which KanMX4 was replaced by either ADE2
(ADEnine requiring) or URA3 (Table 2) [31]. The ELO3 gene
was also deleted in YPK11, a strain isogenic with YPK9, using an
elo3::his5+ cassette obtained by PCR using the pFA6a-His3MX6
plasmid [32] as a template. All deletions were verified by PCR
using DNA preparations of the various strains as templates.
Analysis of [3H]myo-inositol labelled lipids
Unless stated otherwise, metabolic labelling, cell disruption, lipid
extraction and analysis were carried out as described previously
[33]. Where indicated, lipids were subjected to mild alkaline
treatment using 0.1 M NaOH in methanol for 1 h at 37 ◦C. Sol-
vent system 1 [CHCl3/CH3OH/NH4OH, (40:10:1 by vol.)] or
system 2 [CHCl3/CH3OH/0.25% KCl, (55:45:5 by vol.)] were
used in ascending TLC on silica gel plates (Silica Gel 60, Merck).
Radioactivity was detected and quantified by one-dimensional
radioscanning (Berthold) and fluorography. Preparation and
analysis of [3H]myo-inositol labelled GPI anchor lipids was done
as described previously [34].
MS analysis of lipid
For supplementary Figure S1 (see http://www.BiochemJ.org/bj/
401/bj4010205add.htm for details) and a series of similar ex-
periments, exponentially growing cells were resuspended in
CHCl3/CH3OH (1:1, v/v), and thoroughly disrupted by freeze/
thawing and shaking with glass beads. Lipids were in glass
vials throughout and were dried with nitrogen. Lipids were left
untreated or were deacylated with NaOH, and were then parti-
tioned between butanol and 0.1 mM EDTA and 5 mM Tris/HCl,
pH 7. Lipids were resuspended in CHCl3/CH3OH (1:1, v/v)
and analysed with a Bruker 4.7 T BioAPEX II FT/ICR mass
spectrometer in the negative ion mode. Lipids were injected at
various concentrations at a flow rate of 2 µl/min with a tension
of −250 V at the capillary exit. For each spectrum, 20–30 scans
were averaged. All tandem MS experiments were performed with
argon as collision gas at a pressure of 8 mbar.
In another series of experiments, a different lipid extraction
method allowing to also extract MIPCs and M(IP)2Cs and HPLC-
ESI (electrospray ionization)-MS/MS technology were used.
Exponentially growing cells (D600 of 1–2) were extracted as
described [35], using procedure IIIA. Aliquots in CHCl3/CH3OH
corresponding to 1 A600 unit of cells were heated to 65 ◦C for
15 min to solubilize M(IP)2C and immediately injected into a
PVA SIL HPLC column (1 mm × 150 mm; YMC Europe GmbH,
D46514 Scherbeck, Germany), and eluted at 45 µl/min. Solvents
A, hexane/propan-2-ol (98:2, v/v); B, CHCl3/propan-2-ol (65:35,
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v/v); and, C, CH3OH were changed linearly over time to give
ratios A:B:C as follows: Start, 100:0:0; 22 min, 12:88:0; 30 min,
10:74:16; 45 min, 8:61:31; 50 through 65 min, 0:0:100; 70
through 72.5 min, 0:100:0; 75 through 82.5 min, 100:0:0. Lipids
from WT (wild-type) cells grown in [13C]glucose and [12C]inositol
were used as internal standards. Ions in the effluent were ionized
by ESI with an electrode potential of 3500 V and the masses of
negative ions were detected by a Bruker Esquire-LC ion trap mass
spectrometer.
Maturation of secretory proteins
For pulse–chase analysis, cells were metabolically labelled with
35S-containing amino acids as described previously [36],
with one modification: after the addition of SDS to 1% (w/v),
the lysate was incubated at 95 ◦C for 5 min.
Membrane association assay
Cells were grown at 30 ◦C in YPD to exponential phase, and 10–
20 A600 units were collected, washed once in water and worked
up for the membrane association assay as described before [7].
Proteins were precipitated with trichloroacetic acid and ana-
lysed by reducing SDS/PAGE (7.5 % gels). Western blots
were probed with rabbit anti-Pma1p (1:10000), rabbit anti-
Gas1p (1:20000) or mouse anti-CPY (1:1000) antisera and
AlexaFluor®680 anti-rabbit (1:5000) or AlexaFluor®680 anti-
mouse (1:5000) secondary antibodies for detection with the fluor-
escence Odyssey Imaging system (LI-COR).
RESULTS
YPK9 4 (lag1∆ lac1∆ ypc1∆ ydc1∆) cells are rescued
by Lass5 expression
The simultaneous deletion of acyl-CoA-dependent ceramide
synthases (LAG1 and LAC1) in the YPK9 background is lethal
[11]. YPK9 4 cells harbouring LAG1 on an URA3 vector
(4.LAG1 cells) in which the acyl-CoA-independent ceramide
biosynthesis enzymes are also deleted, could not lose their
covering plasmid either (results not shown). Transfection of a
single copy vector harbouring Lass5 under the control of the
MET17 promoter allowed 2.LAG1 and 4.LAG1 cells to
readily form colonies on 5-fluoro-orotic acid-containing media
and hence to lose LAG1. The resulting 2.Lass5 and 4.Lass5
cells grew at all temperatures between 24 and 37 ◦C (Figure 2A).
Cells grew best in YPD medium, grew reasonably in LM, but
only very slowly in minimal medium and were strictly inositol
auxotrophic. When the MET17 promoter was induced (about
1.75-fold) by removal of methionine from the standard growth
medium, there was no effect on the growth rate. As shown in
Figure 2(B), the 4.Lass5 cells were hypersensitive to Calcofluor
White, indicating increased synthesis of chitin. Strains containing
additional deletions (4.Lass5.elo3∆, 4.Lass5.lip1∆) will be
discussed below.
Biosynthesis of sphingolipids in 4.Lass5 cells
To understand whether 4.Lass5 cells had the ability to make
sphingolipids, the cells were labelled with [3H]inositol and lipid
extracts were analysed by TLC. As shown in Figure 3(A),
4.Lass5 cells made several base resistant lipids that migrated
in a similar manner to the IPCs and MIPC of WT cells, but with
slightly different Rf values. The ensuing HPLC–ESI-MS analysis,
however, suggested that the 4.Lass5 sphingolipids co-migrating
with WT IPCs, having a total of three, four or five hydroxyl
Figure 2 Temperature and Calcofluor White sensitivity of 4.Lass5
Serial 10-fold dilutions of cells were plated on YPD + uracil + adenine agar plates. (A) Plates
were incubated at 24, 30 or 37◦C. (B) Plates contained 0, 25 or 50 µg/ml of Calcofluor White
(CFW) and were incubated at 30◦C. All plates were photographed after 3 days.
groups in their ceramide moiety (IPC3, IPC4 and IPC5), are in
fact IPC2, IPC3 and IPC4 forms respectively, which migrate less
than the similarly hydroxylated WT species because they contain
shorter fatty acids than WT IPCs (see below). Figure 3(A) and
Table 3 also show that 4.Lass5 cells make reduced amounts of
sphingolipids in metabolic labelling experiments, which is also
true for 4.Lass5.elo3∆ and 4.Lass5.lip1∆ (discussed further
below). The specificity of the Lass5-dependent ceramide synthesis
was explored further in microsomal ceramide synthase assays. As
shown in Figure 3(B), ceramides were synthesized in the presence
of C12:0–, C14:0–, C16:0–, C18:0– or C18:1–CoA, but not with C20–
, C24:0– or C26:0–CoA. The last two are the preferred substrates
of yeast LAG1- and LAC1-, and human LASS1-, LASS2- and
LASS4-dependent ceramide synthases, when assayed in yeast
microsomes under the same conditions [25] (Table 1). Thus, it
appears that the fatty acid specificity of Lass5 overexpressed in
human and yeast cells is very similar (Table 1).
c© 2007 Biochemical Society
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Figure 3 4.Lass5 make abnormal IPCs and use C16– and C18–CoA for
ceramide synthesis
(A) The indicated strains were labelled with [3H]inositol, washed, and lipids (plus intracellular
free [3H]inositol) were extracted. Aliquots of extract corresponding to 106 c.p.m. (counts per min)
were treated with NaOH (lanes 1–5) or control incubated (lanes 6–10) and desalted lipids were
separated by TLC in solvent system 2. IPC2, IPC3, IPC4 and IPC5 and numbers 2, 3 and 4 next
to lane 2 designate types of IPC, which contain a total number of 2 to 5 hydroxy groups in their
ceramide moiety. The numbers next to lane 2 are rendered likely by HPLC–ESI-MS/MS results
(Figure 4 and supplementary Figure S1). (B) Microsomes of 4.Lass5 were radiolabelled for 2 h
with [3H]DHS in the presence of the indicated acyl-CoAs (0.1 mM) or free fatty acids (0.1 mM)
for control. The radiolabelled lipids were extracted, analysed by TLC using solvent system 1 and
quantitated by radioscanning. Counts present in ceramide were given as the percentage of total
counts present in the lane. No ceramides were made when microsomes were incubated with free
fatty acids (results not shown). ** Tubes containing boiled microsomes were used as a further
control.
Sphingolipid profile of 4.Lass5 cells in HPLC-ESI-MS
To analyse further what sphingolipids the yeast cells could make,
when they depended on a LCFA-specific ceramide synthase such
as Lass5 and on endogenous acyl-CoA biosynthesis, the lipids of
exponentially growing cells were extracted and analysed by
HPLC–ESI-MS (supplementary Figure S1). In all experiments
of this type, IPCs of WT cells contained base resistant m/z peaks
corresponding to IPCs with 42 or 44 C atoms in their ceramide
moiety. Since most yeast sphingolipids contain LCBs with 18 C
atoms, this suggests that the IPCs of YPK9 contained the usual
C24 and C26 fatty acids. In contrast, the main IPCs of 2.Lass5
and 4.Lass5 contained 34 or 36 C atoms suggesting that they
contained C16 and C18 fatty acids (supplementary Figures S1A
and S1B). On the other hand, the profile of glycerophospholipids
was similar in WT and 4.Lass5 (supplementary Figure S1A).
The most abundant IPC of 4.Lass5 and 2.Lass5 cells (IPC16-2
in supplementary Figure S1) contains DHS, although previous
analysis of lipids in WT cells shows that IPCs contain PHS, not
DHS [2,37]. However, DHS is the natural substrate for mam-
malian ceramide synthases [38]. The relative predominance of
IPC2 over the more polar IPC3 and IPC4 species (supplementary
Figure S1) is also reflected in Figure 3A and Table 3, where the
most hydrophobic (farthest migrating) species are quantitatively
major, thus allowing the tentative assignments shown in
Figure 3A, lane 2. Furthermore, the predominance of C16 and C18
fatty acids in IPCs of 4.Lass5 cells was in close agreement with
the specificity of the activity measured in microsomes (Figure 3B).
Sphingolipid profile of 4.Lass5 cells in HPLC-ESI-MS/MS
The ESI-MS results were confirmed by a further series of experi-
ments using HPLC-ESI-MS/MS to reduce the risk of ion sup-
pression. Thereby we also used a different lipid extraction
protocol designed for quantitative extraction of all classes of yeast
sphingolipids and at the same time compared 4.Lass5 with
ypc1∆ydc1∆, a strain that is more closely related to 4.Lass5
than the YPK9 WT strain. Figure 4 presents selected data from
several experiments yielding very similar results, and again shows
that most IPCs and MIPCs of 4.Lass5 contained between 34 and
36 carbon atoms and two, three or four hydroxy groups in their
ceramide moiety (labelled 18-16-2, 18-16-3, 18-16-4, 18-18-3
and 18-18-4 to indicate the probable number of carbon atoms in
the LCB, C atoms of the fatty acid and the sum of hydroxyls
in the ceramide moiety respectively). Greater than 97% of IPCs
and MIPCs of YPK9 and ypc1∆ydc1∆ control cells contained
fatty acids with 22 to 26 carbon atoms. In Figure 4(A), lipid
extracts from WT cells grown in [13C]glucose were used as
internal standards and HPLC-ESI-MS/MS analysis detected the
corresponding [13C]IPC peaks of similar magnitude in all runs.
This shows that the striking absence in 4.Lass5 cells of IPC18–
24, IPC18–26 and IPC20–26 cannot be due to some specific ion
suppression in this strain. While ceramide moieties of most IPCs
of 4.Lass5 contained C16 and C18 fatty acids, small amounts of
IPCs with VLCFAs were still present (barely noticeable in
Figure 4A). To quantitate them we used high concentrations of
mild alkaline treated lipids: IPC18-26-5 and 20-26-5 amounted
to 0.6% and 0.22% of total detectable IPCs respectively.
The only MIPCs we found in 2.Lass5 and 4.Lass5 cells
contained DHS–C16:0, whereas in WT or ypc1∆ydc1∆ only
MIPCs with three or four hydroxy groups were detectable
(Figure 4B). Thus, the mannosyltransferases Csg1p and Csh1p
are able to act on C16- and DHS-containing IPCs (IPC1816-2)
while their physiological substrates probably are IPC18-26-3 and
IPC18-26-4 (Figure 4B) [39,40]. The predominance of MIPC18-
16-2 over other MIPCs in 4.Lass5 cells may reflect a relative
abundance of IPC18-16-2, but it cannot be ruled out that in
4.Lass5 cells Csg1p and Csh1p prefer IPC18-16-2 to other
abnormal substrates or that the specificity of these enzymes is
changed as a consequence of the abnormal sphingolipid content
of surrounding membranes.
Yeast harbours Ole1p (OLEic acid requiring), a desaturase
producing C16:1–CoA and C18:1–CoA and a majority of the fatty
acids in glycerophospholipids are unsaturated. Since C18:1 was
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Table 3 Incorporation of [3H]inositol into sphingolipids
The experiment shown in Figure 3(A) was performed two to seven times and the radioactivity of sphingolipids (as percentage of total labelled lipids) and of individual IPC types (as percentage of
total IPCs) were calculated on the basis of radioscans of the TLC plates.
Strain No. of experiments Sphingolipids (% of lipids) IPC2 (% of IPCs) IPC3 (% of IPCs) IPC4 (% of IPCs)
2Lass5 2 22.6 +− 7.2 46.9 +− 3.5 36.8 +− 1.4 16.3 +− 2.2
4Lass5 5 11 +− 4.1 46.3 +− 2.6 42.2 +− 2.8 11.5 +− 1.8
4Lass5 elo3 5 13.8 +− 4.7 46.9 +− 5.2 38.9 +− 5.2 14.2 +− 2.2
4Lass5 lip1 5 10.3 +− 2.3 50.9 +− 2.2 38.5 +− 2.0 10.5 +− 1.8
YPK9 7 64.4 +− 11.9 - - -
a good substrate for Lass5 in vitro (Figure 2B), we expected
to see subtantial amounts of unsaturated fatty acids in the IPCs
of 4.Lass5 cells. Yet, while mono-unsaturated fatty acids were
predominant in PI and PE (phosphatidylethanolamine), as expec-
ted (supplementary Figure S1), the most prominent unsaturated
IPC of 4.Lass5 cells (m/z = 810 for IPC18-16-4 with one double
bond) only amounted to 3.3% of the corresponding saturated
species (m/z = 812). Also, we could not detect any ceramides
with unsaturated fatty acids in 4.Lass5 cells and the profile of
ceramides in these cells closely resembled the ceramides that were
found in IPCs (results not shown). Thus, Lass5 does not appear
to use unsaturated fatty acids in vivo.
C24 fatty acids remain essential in 4.Lass5 cells
Overall, the HPLC-ESI-MS/MS results showed that 4.Lass5
cells made large amounts of sphingolipids, but that most of them
did not contain VLCFAs. In this context, we wondered if the
VLCFAs were still required for cell survival. We therefore tried
to delete the ELO3 and TSC13 genes (Figure 1). Clones with
the correct replacement of ELO3 by KanMX4 were obtained
easily. In liquid YPD medium, the 4.Lass5 elo3 cells grew
much more slowly than 4.Lass5, but they grew better in LM.
On agar plates, however, 4.Lass5 elo3 cells grew as well
as 4.Lass5 cells (Figure 2). Metabolic labelling indicates that
4.Lass5 elo3 cells incorporate [3H]inositol into sphingolipids
as fast as 4.Lass5 cells (Figure 3A, lane 2 compared with
lane 5; Table 3). In contrast, an attempt to replace TSC13
with KanMX4 in 4.Lass5 failed, in that 12 out of 12 clones
growing on the selective medium still contained TSC13. This
suggests that, although not present in sphingolipids, the VLCFAs
continue to fulfil some vital function in 4.Lass5. This function
possibly is provided by PI′, a PI form having C26:0. PI(44:1)
and PI(42:1) containing C26 in sn-1 have been described as a
minor fraction, making up less than 1% of total PI in WT
cells [41]. PI′ is increased in extracts of [3H]inositol labelled
4.Lass5 cells (Figure 3A, lanes 6–10) and in the HPLC-
ESI-MS/MS lipid profile, 4.Lass5 cells contain 10-fold more
PI(44:1) (m/z = 975.5) and 3-fold more PI(42:1) (m/z = 947.7)
than WT cells (Figure 4C), while no corresponding species were
found for PE and PS (phosphatidylserine; results not shown).
Fragmentation showed that the peak at 975.5 contained C26:0
and C18:1, and that the peak at 947.7 contained C26:0. During
fragmentation the m/z peak 975 lost C18:1 much more readily than
C26:0, indicating that C18:1 is in position sn-2 and C26:0 in sn-1.
4.Lass5 cells transport Gas1p from ER to Golgi
at an almost normal rate
The transport of GPI proteins from ER to Golgi depends on
ongoing ceramide synthesis and the most popular hypothesis pro-
poses that sphingolipids are required for the formation of micro-
domains or rafts, into which GPI proteins have to get integrated
prior to their incorporation into transport vesicles ([5,7,8] and
discussed in [42]). Sphingolipids are necessary for raft formation
and can be assumed to have an influence on the membrane
thickness of lipid rafts, as yeast sphingolipids normally contain
C26 and C24 fatty acids. We therefore investigated if the C16-
and C18-containing sphingolipids of 4.Lass5 could still form
functional rafts and assist GPI protein export from the ER in
a normal way. Raft association of Gas1p is reflected by its
resistance to Triton X-100 extraction at 4 ◦C [7,8]. Of the mature
form of Gas1p, 62% was Triton X-100 resistant in WT cells,
whereas only 36% mature Gas1p was detergent insoluble
in 4.Lass5 (Figure 5A). For comparison, the corresponding
percentage was only 32% in the temperature-sensitive lcb1-100
strain grown at 24 ◦C on rich medium, from which it could take
up some LCBs (Figure 5A). In addition, the blots showed an
abnormal accumulation of immature Gas1p in lcb1-100, but not
in 4.Lass5 cells. Blotting with anti-CPY indicated that there
is no accumulation of the ER and Golgi proforms p1 and p2
in 4.Lass5, whereas its ER form p1 readily accumulated in
sec18 cells at restrictive temperature (37 ◦C) [43] (Figure 5B).
Pulse–chase experiments detect a delay in Gas1p transport in
a more sensitive manner than blotting experiments. In a pulse–
chase experiment, Gas1p was transported at a slightly reduced
rate from the ER to the Golgi in 4.Lass5, whereas CPY was
transported normally (Figures 5C and 5D). The retardation of
Gas1p transport was, however, only very small in comparison
with the dramatic delay revealed by pulse–chase experiments in
elo3∆ or myriocin-treated cells [5,9]. Also, no accumulation of
the immature 105 kDa form of Gas1p was observed by Western
blotting in extracts of elo3-2 or 4.Lass5 elo3 cells, in
three experiments (results not shown). These results indicate
that the ceramides and IPCs of 4.Lass5 allow for a relatively
efficient transport of Gas1p from the ER to the Golgi, although
the incorporation or retention of Gas1p in rafts is somewhat
compromised. As the thickness of membranes might influence
sorting in the secretory pathway [44,45], we tested for secretion
of the vacuolar hydrolase CPY, the sorting of which is dependent
on the correct sorting of the integral membrane protein Vps10p
(carboxypeptidase Y-deficient 10). 4.Lass5 cells did not secrete
CPY as determined by Western blotting, and also did not se-
crete Kar2p (karyogamy 2), an ER chaperone that is secreted when
cells react to stress by an unfolded protein response [46] (results
not shown). The plasma membrane H+-ATPase Pma1p, a classical
raft marker, was found to be completely resistant to extraction with
Triton X-100 in 4.Lass5 cells grown at 30 ◦C, indicating raft
association, but there was approx. 3-fold less Pma1p compared
with WT, suggesting that the rafts of 4.Lass5 cells are only
partially achieving Pma1p stabilization at 30 ◦C (results not
shown).
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Figure 4 Sphingolipids from 4.Lass5 cells contain mainly C16:0 and C18:0
fatty acids by HPLC–ESI-MS/MS
All sphingolipid classes were extracted quantitatively [35] from cells growing exponentially in
LM at 30◦C and analysed by HPLC–ESI-MS/MS. YPK9, ypc1 ydc1 (yy) and 4.Lass5
cells were all grown with methionine (4.Lass5+), 4.Lass5 also without methionine (4.
Lass5−). Parent ion and fragment ion masses (m/z) were recorded throughout the HPLC run
and were screened for all theoretically possible sphingolipids containing different saturated,
monounsaturated, mono- or di-hydroxylated fatty acids combined with DHS or PHS as well as for
conventional phospholipids [40]. The vertical axis in all panels gives the ion counts in thousands.
All species shown in (A) were identified as phosphoinositides by characteristic fragment ions
at m/z 259 and 241, corresponding to inositolphosphate and inositolphosphate–H2O, except
for those that were less than 1 % of the most predominant IPC. However, the LCB could not
be identified by fragmentation and sphingolipids were annotated by three consecutive numbers
to indicate the probable number of carbon atoms in the LCB, the probable number of carbon
atoms in the fatty acid, and the sum of hydroxy groups in the ceramide moiety respectively. (A)
The lipid extracts were mixed with lipid extracts from WT cells grown in [13C]glucose as the
only carbon source and the results were normalized using this internal standard. The normalized
number of ions derived from IPCs present in extracts of 4.Lass5+, 4.Lass5− and ypc1
ydc1 amounted to 183 %, 92 % and 106 % of the WT (YPK9) respectively. (C) The PIs are
specified by two consecutive numbers indicating the total number of carbon atoms and double
bonds present in the two fatty acids respectively. The Figure shows one representative of several
experiments yielding very similar results.
Figure 5 Raft association and transport of Gas1p in 4.Lass5
(A) 4.Lass5 was grown in LM (His−, Met−), 4.LAG1 in LM (−ura) containing galactose
instead of glucose, YPK9 and lcb1-100 in YPD. All cells were grown at 30◦C except for lcb1-100,
which was kept at 24◦C. Exponentially growing cells were lysed with glass beads and aliquots of
lysate were solubilized in Triton X-100 for a membrane association assay (see the Materials and
methods section). Triton X-100 lysates were subjected to ultracentrifugation, the soluble (SN)
and the pellet (P) fractions were processed for Western blotting using anti-Gas1p (A) or anti-
CPY antibodies (B), allowing the detection of mature (m) and precursor (p) forms.
(A) Quantitation of results of top panel and of a second identical experiment is also shown. In (B)
sec18∆ cells were incubated at 37◦C for 0, 1 and 3 h before lysis. For kinetic analysis of Gas1p
(C) and CPY (D) maturation, yeast cells were metabolically labelled with [35S]methionine and
[35S]cysteine, the label was chased for 0–60 min and Gas1p and CPY were immunoprecipitated
from cell extracts, resolved by SDS/PAGE, and detected by phosphoimaging and by fluorography.
Relative amounts of mature proteins are indicated in bottom panels.
4.Lass5 cells remodel the lipid moieties of GPI proteins normally
The lipid moieties of mature GPI-anchors do not usually con-
tain the diacylglycerol, which is present on the GPI lipid at the
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stage when it is transferred by the transamidase to GPI proteins,
and which probably contains the C16 and C18 fatty acids typical
of yeast PI. Most mature GPI proteins of yeast contain a
ceramide moiety, whereas a minor fraction contains a modified
diacylglycerol containing C26:0 in sn-2 [47,48]. Yet, certain yeast
mutants do not incorporate any ceramides in their GPI anchors
[49]. We thus wondered if GPI anchors of 4.Lass5 cells
contained any ceramides. For this, cells were labelled with
[3H]inositol and the labelled lipid moiety of GPI anchors was
analysed by TLC. As shown in Figure 6 (lane 2), the anchors
of WT cells contained the usual pG1, a form of PI having
C26:0 in sn-2, IPC3 (containing PHS–C26:0) and minor amounts
of IPC4 (containing PHS–C26:0-OH) [33,48]. pG1 was sensitive
to mild alkaline conditions, IPCs were not, as expected (Figure 6,
lanes 2 and 3). Very surprisingly, the profile of anchor lipids of
4.Lass5 was normal. The presence of some not yet remodelled
pG2 is also occasionally seen in WT cells (Figure 6, lanes 4
and 5). The anchor-derived IPCs of 4.Lass5 cells migrated
differently from the free IPCs isolated from the very same cells
(Figure 6, compare lane 5 with lane 6). The same difference
between anchor-derived and free IPCs was also found in 2.Lass5
cells (Figure 6, lanes 9 and 10). Thus, in spite of making large
amounts of abnormal IPCs, 4.Lass5 cells seem to incorporate
normal ceramides into their GPI anchors. It may be that the GPI
ceramide remodelase exclusively utilizes the small amounts of
C26-containing ceramides, which also are present in the small
amounts of IPC18-26-5 and IPC20-26-5 of 4.Lass5 cells (see
above).
Lip1p is not required for Lass5p-dependent ceramide synthase
activity in yeast
Lag1p and Lac1p interact with each other and with a third
membrane protein, Lip1p, the latter being equally required for
acyl-CoA-dependent ceramide biosynthesis [15]. To see if Lip1p
is required for acyl-CoA-dependent ceramide synthase activity
of the LAG1 homologue Lass5, we tried to delete the essential
LIP1 gene in 4.Lass5 cells. Transformation of the KanMX4-
containing deletion cassette yielded numerous geneticin resistant
clones and subsequent PCR reactions confirmed that in some
of them KanMX4 had successfully replaced LIP1 (results not
shown). Thus, replacement of LAG1 and LAC1 by Lass5 renders
LIP1 non-essential. As shown in Figure 3(A), the sphingolipid
profile of 4.Lass5 lip1 was similar to the one of 4.Lass5
(Figure 3A, lanes 3 and 5), and quantitation by radioscanning
of TLC plates in several experiments of the type shown in
Figure 3(A) showed that the incorporation of [3H]inositol into
sphingolipids in 4.Lass5 lip1 cells was not slower than in
4.Lass5 cells (Table 3). Moreover, the relative amounts of the
three mild alkaline resistant lipid species observed in [3H]inositol-
labelled lipid extracts of 4.Lass5 and 4.Lass5 lip1 were
similar (Table 3). Lip1p was also not required for the incorporation
of sphingolipids into GPI anchors (Figure 6, lane 16). Although
4.Lass5 lip1 cells were slightly thermosensitive at 37 ◦C
(Figure 2A), they were otherwise as robust as 4.Lass5 cells
(Figure 7A), in keeping with the idea that the main function of
Lip1p is to stabilize yeast Lag1p and Lac1p.
Several phenotypes of elo3∆ and lcb1 mutants are not present in
4.Lass5 cells
The fact that TSC13 could not be deleted in 4.Lass5 cells sug-
gested that VLCFAs continued to play an essential role in yeast
cells, even though most of them were no longer associated with
sphingolipids. In an attempt to identify functions, which LCBs and
Figure 6 GPI anchor lipids of WT and mutant 4.Lass5 cells are similar
Labelling of 25 A 600 units of YPK9 (WT), 4.Lass5, 2.Lass5, 4.Lass5 elo3 (lane 15)
and 4.Lass5 lip1 (lane 16) cells for 2 h with 100 µCi of [3H]inositol. Free lipids were
extracted, GPI proteins were completely delipidated and their lipid moieties were liberated using
HNO2, with the exception of lane 13. Free lipids (L, lanes 1, 6–9 and 12) and liberated anchor
lipids (A, lanes 2–5, 10, 11 and 13–16) were treated with NaOH (+) or mock incubated (−)
for deacylation, separated by TLC and exposed for fluorography. IPCs were annotated as in
Figure 3(A).
VLCFAs may only be able to exert, when combined with each
other, we monitored 4.Lass5 cells for the presence of several
of the well-documented abnormal phenotypes of elo3 or lcb1
cells. The V1 subunit of the vacuolar H+-ATPase was reported to
be defective in elo3 cells and this resulted in a set of phenotypes
referred to as Vma−, which comprises a reduced uptake of
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Figure 7 Phenotypic analysis of 4.Lass5 cells under various stress conditions
Serial 10-fold dilutions of cells were plated on buffered (A and D) or unbuffered YPD + uracil + adenine plates containing the indicated ingredients. Plates were then incubated at 30◦C and
photographed after 3 days except for panel (D), where they were grown at 24◦C for 3 days. 4.LAG1 cells were grown in YPG before being plated on YPD, where they strongly reduce sphingolipid
biosynthesis but, nevertheless, continue to grow for several days. The vma4 cells served as a positive control and exhibited the same Vma− phenotype as described for vma2 and vma13 [23].
quinacrine into vacuoles, calcium and zinc hypersensitivity and
inability of cells to grow at high pH or on glycerol [23].
Furthermore, lcb1 SLC1-1 cells have difficulty to grow in high
salt, low pH or at 37 ◦C [50]. We thus tested the growth of
4.Lass5 cells under these conditions. As shown in Figure 7(A),
elo3-2, carrying deletion of ELO3 in the YPK9 background,
were hypersensitive to Zn2+ but not to Ca2+; the 4.Lass5
cells were not hypersensitive to these two cations and deletion of
ELO3 in this background did not cause any cation hypersensitivity
(Figure 7A). Thus, for elo3 cells to exhibit Zn2+ hypersensitivity,
the VLCFA and LCB may have to be linked, and it may be the
predominance of C22- and C24-containing sphingolipids, rather
than the absence of C26-containing sphingolipids that affects
the function of the vacuolar H+-ATPase of elo3-2 cells [23].
Also, in the YPK9 background, ELO3 was not required for
the accumulation of quinacrine in vacuoles. The 4.Lass5 and
4.Lass5 elo3 cells also accumulated quinacrine quite nor-
mally, although there was more heterogeneity in vacuolar morpho-
logy and quinacrine uptake in those mutants than in the YPK9
WT (results not shown). Similarly, neither elo3-2 nor 4.Lass5
cells were found to be sensitive to pH 6.7, and at higher pH (7.3)
not only 4.Lass5, but also the parental YPK9 cells showed
reduced growth (results not shown). Thus, apart from Zn2+ hyper-
sensitivity, we were unable to detect Vma− phenotypes in elo3
mutants generated in either the YPK9 or BY4742 background and
no Vma− phenotypes were present in 4.Lass5 cells or 4.Lass5
elo3 cells.
As for lcb1 phenotypes, 4.Lass5 cells grew well at low pH
(4.1; Figure 7C) and at 37 ◦C (Figure 2A), but they grew badly
on 1M NaCl (Figure 7A). Moreover, they were Calcofluor White
hypersensitive (Figure 2B), but they were not more sensitive to
SDS than WT cells (results not shown), indicating that they were
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not osmotically fragile [51]. Thus, 4.Lass5 cells expressed some
but not all of the phenotypes described in lcb1 SLC1-1 cells.
Remarkably, the salt and Calcofluor White sensitivity of 4.Lass5
was rescued by deletion of ELO3 (Figures 2B and 7A), suggesting
that under stress conditions C26:0 fatty acids, which cannot be
integrated into sphingolipids, exert toxic effects that are not seen
with C22:0 and C24:0 fatty acids.
Deletion of ELO3 provides resistance to haloperidol in WT
as well as 4.Lass5 cells
Deletion of ELO3 has also been reported to confer resistance to
SR31747 and fenpropimorph, two inhibitors of the ergosterol
biosynthesis enzymes Erg2p and Erg24p, and to abolish the
growth defect of erg2 mutants [21,22]. As SR31747 was not
available to us, we used haloperidol, another specific inhibitor
of Erg2p [52]. As shown in Figure 7(B), elo3-2 cells indeed
were resistant to haloperidol, while 4.Lass5 cells were as
sensitive as the WT strain. The ypc1 ydc1 strain was also
more resistant than WT cells, but far less than elo3-2 cells. The
elimination of ELO3 from 4.Lass5 cells significantly increased
their haloperidol resistance. The result suggests that C26:0 fatty
acids are inhibitory to the growth of erg2∆, even if they are not
present in sphingolipids, while C22 and C24:0 fatty acids are better
tolerated by erg2∆.
The 4.Lass5 cells were sensitive to aureobasidine A, an
inhibitor of IPC synthase Aur1p, as were WT and ypc1 ydc1
cells (Figure 7D). This suggests that the proposed toxicity of
ceramides [13] is exerted not only by the natural VLCFA-cera-
mides but also by C16- and C18-ceramides. The proposed toxicity
of ceramides can also explain the aureobasidine A hypersensiti-
vity of ypc1 ydc1 cells (Figure 7D).
Bud-site selection has been reported to be deficient in both
diploid and haploid elo3∆ cells [24]. While the presence of this
defect was confirmed for the strain used by Ni et al. [24], we could
not find a similar effect of ELO3 deletion in the background of
YPK11 (see supplementary Figure S2 at http://www.BiochemJ.
org/bj/401/bj4010205add.htm; see elo3-2), even when growing
cells at 37 ◦C (results not shown). Also, neither 4.Lass5 nor
4.Lass5 elo3 cells showed the defect.
Globally, it looks as if several of the described phenotypes of
elo3 cells do not manifest themselves in the YPK9 background,
and that of those that are present, Zn2+ hypersensitivity and
haloperidol resistance, only the latter is also observed when ELO3
is deleted in the 4.Lass5 background.
DISCUSSION
Our study was initiated to confirm that the fatty acyl-CoA
specificity of the acyl-CoA-dependent ceramide synthase activ-
ities is determined by the Lag and Lass proteins, and not by
some other proteins. This idea was supported by the finding
that overexpression of different Lass proteins in mammalian cells
resulted in ceramide synthase activities with preferences for acyl-
CoAs of different chain length and the analogous findings
obtained through the expression of different human LASS proteins
in yeast (Table 1). The idea received further support through two
recent studies showing that the detergent-purified yeast Lag1p–
Lac1p–Lip1p complex, as well as purified murine Lass5 protein
exhibit the same preferences for fatty acid chain lengths that
were observed in microsomal assays [15,53]. It, nevertheless,
still seems possible that the membrane environment could also
influence the specificity of ceramide synthases. Indeed, the Lag1
complex could only be obtained in an active form when solubilized
by digitionin [15], a detergent that is not apt to remove all lipids
from membrane proteins. Similarly, the activity of purified Lass5
was strongly enhanced by the addition of glycerophospholipids,
whereby it is not known if the fatty acid composition of added
lipids has any influence on the acyl-CoA specificity of the enzyme
[53]. In this context, it is interesting to note that Lass5 expressed
in yeast cells exhibits a very similar specificity in vitro and in vivo
as was measured for the same enzyme expressed in mammalian
HEK-293 T cells (Figure 3B; Table 1). (In vivo we did not find
C12- and C14-sphingolipids in 4.Lass5 cells, probably because
C12– and C14–CoA are present in very low concentrations in
living cells). Thus, LAG1 and Lass5 expressed in the very same
background, induce ceramide synthases with very different fatty
acids specificities. However, even this finding cannot definitively
eliminate a role of the membrane environment in fatty acid specifi-
city of ceramide synthases, since the very absence of Lag1p
in 4.Lass5 cells may alter the membrane environment in the
ER where these enzymes act. Analysis of the acyl-CoA specifi-
city of purified enzyme reconstituted into different lipid environ-
ments may shed further light on this question. The abnormally
high proportion of DHS-based sphingolipids in 4.Lass5 cells
suggests that Lass5 also somehow dictates the LCB specificity of
the ceramide synthase.
It should be noted, that of the five murine LAG1 homologues,
Lass5 is the only one able to utilize oleic acid (9-C18:1) [27,54].
Oleyl–CoA was efficiently utilized by Lass5 present in yeast
microsomes (Figure 3B), but C18:1-CoA was apparently not
utilized very efficiently in living cells, since no PHS-C18:1 and
DHS-C18:1 ceramides were detected (results not shown). It still
is possible that PHS-C18:1 and DHS-C18:1 were degraded rapidly.
Such degradation could however only be operated by ceramidases
unrelated to Ypc1p and Ydc1p, as these enzymes were deleted in
4.Lass5 cells. Indeed, the present study did not reveal any role
of these ER based alkaline ceramidases in determining the fatty
acid profile of sphingolipids, since the same spectrum of IPCs
was present in YPK9 WT and ypc1 ydc1 cells (Figure 4) and
similarly, no major differences were observed between 2.Lass5
and 4.Lass5 cells (see supplementary Figures S1A and S1B).
However, hypersensitivity of ypc1 ydc1 cells to aureobasidine
A (Figure 7D), suggests that Ypc1p and Ydc1p allow degrading
excess ceramides in the ER.
While Lip1p is an essential component of the Lag1p–Lac1p
complex in yeast, there is no homologous or analogous protein
presently known for mammals. An enzymatically active, affinity-
purified Lass5p preparation consisted of Lass5p and only trace
amounts of other proteins, as judged by SDS/PAGE and Silver
Nitrate staining [53]. The present study has led to the conclusion
that Lass5 does not require additional subunits for its activity, a
conclusion which is further supported by our finding that LIP1 can
be deleted in 4.Lass5 cells without any apparent consequences
for sphingolipid biosynthesis. Indeed, the 4.Lass5 lip1 cells
incorporated as much [3H]inositol into sphingolipids as 4.Lass5
cells (Figure 3A, lane 3 compared with lane 5; Table 3). This
finding also suggests that Lip1p is not required for protecting the
ceramides from degradation, for channelling of ceramides into
secretory vesicles or for other ceramide-related functions that
could only be required specifically in yeast. Thus, the function of
Lip1p seems to be intimately related to the Lag1p–Lac1p enzyme
itself, but other unrelated functions cannot be excluded at this
stage. A similar conclusion was reached in a recent report showing
that murine Lass3 can rescue lip1∆ cells [54].
Our study clearly indicates that C22:0 or longer fatty acids play
a crucial role for cell survival, even if these fatty acids can be
integrated into sphingolipids only very inefficiently. Several res-
ults also suggest that VLCFAs, when outside the normal sphingo-
lipid context, can have adverse effects, and this is much more
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pronounced for C26:0 than for C22:0 and C24:0 fatty acids. Thus,
C26:0 seems to become toxic when 4.Lass5 cells are stressed by
NaCl (Figure 7A), when they are exposed to Calcofluor White
(Figure 2B) and also when the ergosterol C8 isomerase Erg2p is
inhibited (Figure 7B).
We believe that 4.Lass5 cells will be useful for dissecting
the sphingolipid-dependent signal transduction pathways in yeast
further, as well as for a better understanding of the role of sphingo-
lipids and VLCFAs in forming the membrane structure. 4.Lass5
cells may become useful, not only for the analysis of other
ceramide synthases, but also for the study of other mammalian
enzymes involved in the biosynthesis of complex sphingolipids,
since the ceramide profile of 4.Lass5 cells is similar to the one
found in various human tissues.
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